Vectus Biosystems Ltd. operates as a drug discovery and development company. It researches a treatment for fibrosis and high blood pressure, which includes the therapeutics for diseases in the fibrotic market namely heart, kidney, and liver disease. Its lead compounds include VB0004, VB4-A32, VB4-A79, and VB4-P5. The company was founded by Karen Duggan on December 12, 2005 and is headquartered in Rosebery, Australia.

Sunshine Lake Pharma Co. Ltd., a subsidiary of Shenzhen Dongyangguang Industry Co., Ltd., is a Chinese company. The firm manufactures and supplies pharmaceutical ingredients and drugs. Wen Jia Li has been the CEO since 2021. On December 23, 2022 Shenzhen Dongyangguang Industry Co., Ltd. acquired Sunshine Lake Pharma Co. Ltd. from YiChang HEC ChangJiang Pharmaceutical Co., Ltd. for $330.99 million.

The core competencies and networks needed for successful execution of the EnCare business model fall in three categories. First, a sound scientific base is formed by involving the department at UMCU where the project first came to light. The second category of core competencies is vital for the adding of value to the assets and is biased towards manufacturing, development and interaction with regulatory authorities. This category includes expertise in CMC, preclinical development, regulatory affairs, clinical development, quality control and project management. EnCare management has a strong network of experts in all of these fields, who represent an impressive combined track record in the manufacturing and development of biological and antibodies in particular. Lastly, a third category is business development and finance. The EnCare management team has been heavily involved in business development activities of all flavors and has executed multiple transactions with different partners over the years. In addition, they have well-established connections with the best consultants in the industry in the field of Intellectual Property, transactional law, corporate law, finance and auditing etc. and will leverage these connections to support EnCare. Operationally EnCare is following a very lean model with the controlling functions in-house and the operational activities contracted out with gold-standard external providers.

UMC Utrecht Holding BV engages in utilization and commercialization of academic researches. It offers research support and training services. The company was founded in 1996 and is headquartered in Utrecht, the Netherlands.

Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. It operates through the following segments: Pharmaceuticals, Information Service, and Others. The Pharmaceuticals segment researches, develops, manufactures, and markets drugs, which are used in the fields of urology, dialysis, women's health, ophthalmology, endocrinology and metabolism. The Information Service segment offers information services to use in IT and capital investment. The Others segment includes merchandise sales and construction contractors. The company was founded on August 9, 1946 and is headquartered in Matsumoto, Japan.

Suntory Holdings Ltd. operates as a holding company with interests in the production and distribution of alcoholic and non-alcoholic beverages, health, beauty, and processed food products. Its services include formulation and promotion of group wide management strategies and corporate functions; sale of alcoholic beverages such as whiskey, beer, and wine; soft drinks; and other beverages such as tea and canned coffee. The company was founded by Shinjiro Torii in 1899 and is headquartered in Osaka, Japan.

Guangzhou Medical University New Drug Creation Co., Ltd., established on 2015-08-21, Business scope includes medical research and experimental development;Biomedical Technology Research;Biotechnology Development Services;Biotechnology Transfer Services;drug development;Stem Cell Drug Development;Stem Cell Technology Research,to develop;Health Sciences Program Research Transfer;Technology intermediary service;Biological Products Testing;Clinical Laboratory Services;Manufacturing of chemical raw materials

Nanjing Anji Biotechnology Co., Ltd., established on 2012-04-12, Business scope includes licensed projects:Drug retail;Veterinary drug business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Encell Co. Ltd. is a South Korean company located in Gangnam that operates as a biopharmaceutical research and development company. Jong-Wook Jang is currently the CEO of the firm.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Assistance Publique des Hôpitaux de Paris SA the company is headquartered in Paris, France.

Part of GSK Plc, GlaxoSmithKline Intellectual Property Development Ltd. is a British company located in Middlesex that functions as an investment holding company. It was founded in 2012.\nThe company says this about itself: The Company is a member of the GlaxoSmithKline Group (the \"Group\"). The Company's principal activities are the development, enhancement, maintenance, protection and exploitation of intellectual property assets owned by the Company which may include but are not limited to, licensing out intellectual property rights relating to pharmaceutical products to the GlaxoSmithKline Group of companies (the \"Group\") and carrying out research and development activities.

Shanghai Lanque Biopharmaceutical Co., Ltd., established on 2019-04-24, Business scope includes general items:engaged in biomedical technology,Biological Technology,Chemical Technology,Technology development in the field of detection technology,technology transfer,technical consulting,Technical Services,Engaged in the import and export of goods and technology,Sell ​​laboratory equipment,Class I medical device,Chemical products and raw materials(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals);pharmaceutical production(Limited to branch operations);Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals)(Limited to branch operations).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Hebei Yiling Pharmaceutical Research Institute Co., Ltd., established on 2001-04-19, Business scope includes Chinese patent medicine,Medicine and health products,Traditional Medical Devices,Western medicine,Biological product,Research and Development of Sanitary Dressing;technical consulting,Serve,transfer.(Those requiring special approval shall not operate without approval)

Guangzhou Zhongda Nansha Science and Technology Innovation Industrial Park Co., Ltd., established on 2011-12-07, Business scope includes technical services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Technology intermediary service;software development;Data processing and storage support services;Information Technology Consulting Services;Medical Research and Experimental Development;Information system integration service;Engineering and Technology Research and Experimental Development;Conference and Exhibition Services;Non-residential real estate leases;Sales of Class II Medical Devices;Wholesale medical masks;Medical Mask Retail;Indoor environment detection;Health food production;Health food sales;pharmaceutical production;Pharmaceutical commissioned production;food production;Food additive production;Production of formula food for special medical purpose;Sales of formula food for special medical purposes;Production of Class II Medical Devices;Production of medical masks

Nanjing Drum Tower Hospital is a private company headquartered in China. The firm provides medical services.

The Max Planck Society for the Advancement of Science (German: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V.; abbreviated MPG) is a non-governmental and non-profit association of Research Institutes publicly funded by the federal and the state governments of Germany. Additionally, the Max Planck Society and its Institutes receive third party funding from public and private contributions and from the European Union. The world leading organization is named in honor of its former president, theoretical physicist Max Planck. The 86 Institutes and Research Facilities of the Max Planck Society (as of 2020) conduct basic research in the natural sciences, life sciences, social sciences, and the arts and humanities. They have a total staff of approximately 24,000 permanent employees, including 15,000 scientists, and around 5,000 non-tenured scientists and guests. As of December 31, 2018, the proportion of female employees was 44.4 percent. The Max Planck Society (with its 86 Max Planck Institutes) has a world-leading reputation as a science and technology research organization, with more than 33 Nobel Prizes awarded to its scientists, and is widely regarded as one of the foremost basic research organizations in the world.

Caseair Biotechnology (Suzhou) Co., Ltd., established on 2016-10-19, Business scope includes biotechnology research and development,technology transfer,technical consulting,Technical Services;drug development,Pharmaceutical technology transfer;Laboratory Animal Testing Services;Engaged in the wholesale of similar products and supporting reagents produced by the company,import and export,commission agent(except auction)and related business.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)